In obesity hypoventilation syndrome (OHS), a patient’s gender is not independently linked to worse clinical outcomes after adjusting for age.

A machine learning tool incorporating both clinical and genomic data helps predict response to CDK4/6 inhibitor therapy in ...

The U.S. Food and Drug Administration has approved Galderma's Nemluvio (nemolizumab) for the treatment of moderate-to-severe atopic dermatitis in patients aged 12 years and older.

New York, New York--(Newsfile Corp. - December 19, 2024) - Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into BioAge Labs, Inc. (NASDAQ: BIOA) for potential ...

In addition, it is well-established that bias can influence the findings of meta-analyses that pool results from clinical ...

Researchers identified nicotinamide (NAM) and pyridoxine (PN) as safe, synergistic nutrients that restore muscle stem cell ...

In increasingly polarized times, the intersection of politics and medicine has rarely been so divisive. We examine why these ...

The study is one of five clinical efforts - three proof-of-concept investigator-initiated trials (IIT) and two Phase 2 studies - of crofelemer ...

Additionally, results from preclinical studies provide proof-of-mechanism for recovery of muscle function with ClC-1 inhibition using NMD670 in CMT mouse models Aarhus, Denmark, 18 December 2024 – NMD ...

Huntsman Cancer Institute at the University of Utah (the U) has joined other institutions in an innovative clinical trials ...

Poor sleep quality and later mid-sleep time were associated with significantly higher odds of more severe depression in Parkinson disease.